Education
About Us
Working with TipRanks
Follow Us
Neuronetics Inc (STIM)
NASDAQ:STIM
STIM Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.52 - $5.92
Previous CloseN/A
Volume92.55K
Average Volume (3M)1.33M
Market Cap
$223.50M
Enterprise Value$298.34M
Total Cash (Recent Filing)$11.14M
Total Debt (Recent Filing)$80.66M
Price to Earnings (P/E)―
Beta1.46
Next Earnings
Nov 11, 2025EPS Estimate
-0.13Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.15
Shares Outstanding66,124,820
10 Day Avg. Volume1,418,134
30 Day Avg. Volume1,325,642
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap1.33
Enterprise Value/Revenue2.69
Enterprise Value/Gross Profit4.78
Enterprise Value/Ebitda-7.73
Forecast
1Y Price Target
$7.00Price Target Upside103.49% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Bulls Say, Bears Say
Bulls Say
Future GrowthManagement updated its FY25 guidance, raising the low-end of its revenue range, indicating confidence in future growth.
Revenue PerformanceThe company beat estimates with $38.1M in revenue, driven by $23.0M in Clinic/Greenbrook, which exceeded expectations.
Strategic InitiativesNeuronetics is focusing on increasing the utilization of its systems and increasing revenue from SPRAVATO at Greenbrook clinics as key growth opportunities.
Bears Say
Acquisition RisksThere are underlying risks with acquisitions, particularly given the two different business models at Neuronetics and Greenbrook on top of a continued uncertain macroeconomic environment.
Cash Flow ManagementThe stock traded off on the higher-than-expected cash burn for Q1.
Gross Margin GuidanceManagement ultimately lowered gross margin guidance as Greenbrook will be a bigger piece of overall revenue than initially expected.
Neuronetics News
STIM FAQ
What was Neuronetics Inc’s price range in the past 12 months?
Neuronetics Inc lowest stock price was $0.52 and its highest was $5.92 in the past 12 months.
What is Neuronetics Inc’s market cap?
Neuronetics Inc’s market cap is $223.50M.
When is Neuronetics Inc’s upcoming earnings report date?
Neuronetics Inc’s upcoming earnings report date is Nov 11, 2025 which is in 74 days.
How were Neuronetics Inc’s earnings last quarter?
Neuronetics Inc released its earnings results on Aug 05, 2025. The company reported -$0.15 earnings per share for the quarter, missing the consensus estimate of -$0.078 by -$0.072.
Is Neuronetics Inc overvalued?
According to Wall Street analysts Neuronetics Inc’s price is currently Undervalued.
Does Neuronetics Inc pay dividends?
Neuronetics Inc does not currently pay dividends.
What is Neuronetics Inc’s EPS estimate?
Neuronetics Inc’s EPS estimate is -0.13.
How many shares outstanding does Neuronetics Inc have?
Neuronetics Inc has 66,124,820 shares outstanding.
What happened to Neuronetics Inc’s price movement after its last earnings report?
Neuronetics Inc reported an EPS of -$0.15 in its last earnings report, missing expectations of -$0.078. Following the earnings report the stock price went down -2.575%.
Which hedge fund is a major shareholder of Neuronetics Inc?
Currently, no hedge funds are holding shares in STIM
Neuronetics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$7.00 (103.49% Upside)
$7.00 (103.49% Upside)
Blogger Sentiment
Bullish
STIM Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 171.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $13.0M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.1%
Last 30 Days ▼ 1.7%
Last 30 Days ▼ 1.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
265.61%
12-Months-Change
Fundamentals
Return on Equity
-207.57%
Trailing 12-Months
Asset Growth
39.08%
Trailing 12-Months
Company Description
Neuronetics Inc
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
STIM Company Deck
STIM Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflected a strong performance in revenue growth and strategic initiatives, particularly in clinic expansion and adolescent patient engagement. However, challenges in gross margin and delayed positive cash flow targets indicate areas needing improvement.View all STIM earnings summariesSTIM Stock 12 Month Forecast
Average Price Target
$7.00
▲(103.49% Upside)
Technical Analysis
Ownership Overview
12.96% Insiders
4.34% Mutual Funds
8.72% Other Institutional Investors
67.75% Public Companies and
Individual Investors